Compare Vertex Pharmaceuticals Incorporated (VRTX) vs Wheaton Precious Metals Corp (WPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vertex Pharmaceuticals Incorporated vs Wheaton Precious Metals Corp — how do they compare? Vertex Pharmaceuticals Incorporated trades at $510.6 (market cap $127.55B), while Wheaton Precious Metals Corp trades at $138.77 (market cap $61.17B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 2.1× Wheaton Precious Metals Corp's market cap, and Wheaton Precious Metals Corp pays a 0.58% dividend while Vertex Pharmaceuticals Incorporated pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vertex Pharmaceuticals Incorporated for 120 Days and Wheaton Precious Metals Corp for 66 Days on average.
| VRTX | WPM | |
|---|---|---|
Market Cap | $127.55B | $61.17B |
Volume | 1,487,944 | 1,092,361 |
Sector | Health | Basic Materials |
52-Week High | $557.96 | $165.72 |
52-Week Low | $407.37 | $94.37 |
Typical Hold Time | 120 Days | 66 Days |
Enterprise Value | $121.68B | $63.05B |
Dividend Yield | — | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Vertex Pharmaceuticals (VRTX) trades at $509.98, up 0.86% today, with a bearish technical signal but strong fundamentals. The company reported $12.00B revenue in 2025 with a 35% net income margin and robust cash flow. Recent positive Phase 2b data for inaxaplin in kidney disease and dominant cystic fibrosis market position support growth. Analysts maintain a strong buy consensus with a $573.50 price target, indicating 12% upside potential.
Outlook remains positive driven by pipeline expansion and high profitability, though risks include clinical trial outcomes and market volatility. The stock's valuation at 29.31 P/E is reasonable for its growth profile, but investor sentiment is cautious near-term due to mixed earnings beats and technical weakness.
Wheaton Precious Metals (WPM) trades at $138.1, up 3.3% today, with a bearish technical signal despite recent earnings beats. The company reported record 2025 revenue of $2.31B and net income of $1.47B, supported by strong margins. Analyst consensus is bullish with an 80% buy rating and a $164.80 price target, while news highlights growth ambitions targeting 1.2M ounces by 2030.
WPM offers exposure to gold and silver streaming with robust profitability, but faces risks from gold price volatility and high valuations. The stock's upside hinges on execution of its funded growth pipeline, though technical indicators suggest near-term resistance near $138.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →About Wheaton Precious Metals Corp
Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →
